Insider · CIK 1733464
Saleel Awsare
Full history from EDGAR: holdings now, every transaction and Form 144 planned sales
Open-market buys6
Open-market sales33
Bought$475K
Sold$8.7M
Every trade, with what the company filed around it
Open-market buys and sales as each Form 4 states them, newest first.
How these figures work
Notes on each row are as each Form 4 states them, next to SEC Tracker's own records of the company's filings and other insiders' buys. Holding after is what the filing reports they held after the trade, with the change in their holding.
| Date | Company | Trade | Value | Holding after | Notes |
|---|---|---|---|---|---|
| Sep 9, 2026 | Lantronix LTRX | Bought 15,000 sh at $5.18 13 days after the company's 8-K filed Aug 27, 2026. | $78K | 453,381 +3% | 13 days after the company's 8-K filed Aug 27, 2026. |
| May 13, 2025 | Lantronix LTRX | Bought 15,011 sh at $2.11 1 day after the company's 8-K filed May 12, 2025. | $32K | 268,391 +6% | 1 day after the company's 8-K filed May 12, 2025. |
| Feb 28, 2025 | Lantronix LTRX | Bought 15,000 sh at $2.53 15 days after the company's 8-K filed Feb 13, 2025. | $38K | 253,380 +6% | 15 days after the company's 8-K filed Feb 13, 2025. |
| Nov 13, 2024 | Lantronix LTRX | Bought 80,000 sh at $2.66 5 days after the company's 10-Q filed Nov 8, 2024. | $213K | 233,184 +52% | 5 days after the company's 10-Q filed Nov 8, 2024. |
| May 2, 2024 | Lantronix LTRX | Bought 10,000 sh at $3.66 The same day as the company's 10-Q filed May 2, 2024. | $37K | 30,000 +50% | The same day as the company's 10-Q filed May 2, 2024. |
| Feb 13, 2024 | Lantronix LTRX | Bought 20,000 sh at $3.91 Their first shares, by the holdings the Form 4 states. Their first open-market buy here in SEC Tracker's records. 5 days after the company's 10-Q filed Feb 8, 2024. | $78K | 20,000 | Their first shares, by the holdings the Form 4 states. Their first open-market buy here in SEC Tracker's records. 5 days after the company's 10-Q filed Feb 8, 2024. |
| Sep 15, 2023 | SYNAPTICS SYNA | Sold 5,000 sh at $88.21 The filing does not mark this sale as under a Rule 10b5-1 plan. 10 days after the company's ARS filed Sep 5, 2023. | $441K | 43,084 −10% | The filing does not mark this sale as under a Rule 10b5-1 plan. 10 days after the company's ARS filed Sep 5, 2023. |
| Aug 14, 2023 | SYNAPTICS SYNA | Sold 7,669 sh at $91.16 The filing does not mark this sale as under a Rule 10b5-1 plan. | $699K | 26,362 −23% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Mar 9, 2023 | SYNAPTICS SYNA | Sold 5,000 sh at $115.28 The filing does not mark this sale as under a Rule 10b5-1 plan. | $576K | 33,755 −13% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Dec 9, 2022 | SYNAPTICS SYNA | Sold 4,000 sh at $102.80 The filing does not mark this sale as under a Rule 10b5-1 plan. | $411K | 38,641 −9% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Nov 11, 2022 | SYNAPTICS SYNA | Sold 1,822 sh at $106.58 The filing does not mark this sale as under a Rule 10b5-1 plan. | $194K | 42,474 −4% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Sep 9, 2022 | SYNAPTICS SYNA | Sold 4,000 sh at $123.00 The filing does not mark this sale as under a Rule 10b5-1 plan. | $492K | 34,608 −10% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Aug 25, 2022 | SYNAPTICS SYNA | Sold 3,773 sh at $133.58 The filing does not mark this sale as under a Rule 10b5-1 plan. | $504K | 38,835 −9% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Aug 25, 2022 | SYNAPTICS SYNA | Sold 53 sh at $133.54 The filing does not mark this sale as under a Rule 10b5-1 plan. | $7K | 38,782 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Aug 25, 2022 | SYNAPTICS SYNA | Sold 174 sh at $133.50 The filing does not mark this sale as under a Rule 10b5-1 plan. | $23K | 38,608 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Nov 24, 2021 | SYNAPTICS SYNA | Sold 1,000 sh at $276.00 The filing does not mark this sale as under a Rule 10b5-1 plan. | $276K | 30,844 −3% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Nov 12, 2021 | SYNAPTICS SYNA | Sold 5,000 sh at $250.03 The filing does not mark this sale as under a Rule 10b5-1 plan. | $1.3M | 31,844 −14% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Nov 9, 2021 | SYNAPTICS SYNA | Sold 3,000 sh at $255.00 The filing does not mark this sale as under a Rule 10b5-1 plan. | $765K | 36,844 −8% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Sep 2, 2021 | SYNAPTICS SYNA | Sold 126 sh at $189.72 The filing does not mark this sale as under a Rule 10b5-1 plan. | $24K | 39,855 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Sep 2, 2021 | SYNAPTICS SYNA | Sold 4,732 sh at $189.33 The filing does not mark this sale as under a Rule 10b5-1 plan. | $896K | 35,123 −12% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Jun 4, 2021 | SYNAPTICS SYNA | Sold 1,581 sh at $135.66 The filing does not mark this sale as under a Rule 10b5-1 plan. | $214K | 34,163 −4% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Feb 12, 2021 | SYNAPTICS SYNA | Sold 1,700 sh at $128.89 The filing does not mark this sale as under a Rule 10b5-1 plan. | $219K | 37,045 −4% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Feb 11, 2021 | SYNAPTICS SYNA | Sold 1,769 sh at $125.00 The filing does not mark this sale as under a Rule 10b5-1 plan. | $221K | 38,745 −4% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Feb 8, 2021 | SYNAPTICS SYNA | Sold 500 sh at $122.04 The filing does not mark this sale as under a Rule 10b5-1 plan. | $61K | 41,808 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Feb 8, 2021 | SYNAPTICS SYNA | Sold 1,294 sh at $122.00 The filing does not mark this sale as under a Rule 10b5-1 plan. | $158K | 40,514 −3% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Nov 16, 2020 | SYNAPTICS SYNA | Sold (10b5-1) 139 sh at $79.60 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $11K | 42,308 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Nov 9, 2020 | SYNAPTICS SYNA | Sold (10b5-1) 3,364 sh at $81.61 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $275K | 47,579 −7% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Nov 9, 2020 | SYNAPTICS SYNA | Sold (10b5-1) 1,720 sh at $82.58 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $142K | 45,859 −4% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Nov 9, 2020 | SYNAPTICS SYNA | Sold (10b5-1) 3,112 sh at $83.43 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $260K | 42,747 −7% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Nov 9, 2020 | SYNAPTICS SYNA | Sold (10b5-1) 300 sh at $84.49 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $25K | 42,447 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Aug 10, 2020 | SYNAPTICS SYNA | Sold (10b5-1) 2,107 sh at $85.35 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $180K | 39,134 −5% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Aug 10, 2020 | SYNAPTICS SYNA | Sold (10b5-1) 801 sh at $86.15 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $69K | 38,333 −2% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Aug 10, 2020 | SYNAPTICS SYNA | Sold (10b5-1) 250 sh at $87.88 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $22K | 38,083 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Aug 10, 2020 | SYNAPTICS SYNA | Sold (10b5-1) 113 sh at $88.99 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $10K | 37,970 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| May 11, 2020 | SYNAPTICS SYNA | Sold (10b5-1) 2,851 sh at $65.60 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $187K | 43,529 −6% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| May 11, 2020 | SYNAPTICS SYNA | Sold (10b5-1) 1,384 sh at $66.34 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $92K | 42,145 −3% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| May 11, 2020 | SYNAPTICS SYNA | Sold (10b5-1) 39 sh at $67.14 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $3K | 42,106 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Nov 18, 2019 | SYNAPTICS SYNA | Sold (10b5-1) 267 sh at $58.66 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $16K | 48,048 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jul 17, 2019 | SYNAPTICS SYNA | Sold (10b5-1) 635 sh at $31.88 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $20K | 37,729 −2% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
Open-market trades are Form 4 transaction codes P (purchase) and S (sale). Planned sales are those the filing marks as made under a Rule 10b5-1 plan. A P-code buy at the offering price within a day of the company's FWP, 424B prospectus or offering 8-K is marked Bought in the offering and left out of open-market buy counts and cluster buys. Prices and values are as stated in each Form 4. Stock prices aren't shown on this page. Not investment advice.